Related Experiment Video
Updated: Jun 21, 2026
07:50
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Presumed early-onset sarcoidosis: a case of devastating ocular inflammation in an infant
Rajan Bhojwani1, Anne-Cees Houtman, Paulo Stanga
1Manchester Royal Eye Hospital, Manchester, United Kingdom.
Journal of Pediatric Ophthalmology and Strabismus
|August 4, 2009
Insights
Early-onset sarcoidosis affecting the eye requires immediate, strong immunosuppressive therapy. This aggressive treatment is crucial to prevent vision loss in affected children.
Area of Science:
- Ophthalmology
- Rheumatology
- Pediatrics
Background:
- Early-onset sarcoidosis (EOS) is a rare multisystem inflammatory disease.
- Ocular involvement in EOS can lead to significant visual impairment.
Observation:
- This study highlights the critical involvement of the orbit and posterior segment of the eye in EOS.
- Prompt recognition of these ocular manifestations is essential.
Findings:
- Aggressive immunosuppressive treatment is indicated for ocular EOS.
- Timely intervention is key to mitigating visual morbidity.
Implications:
- Early and intensive treatment strategies can improve visual outcomes in pediatric patients with EOS.
- Multidisciplinary care involving ophthalmologists and rheumatologists is vital for managing EOS-related eye disease.
Abstract:
Involvement of the orbit and posterior segment of the eye in early-onset sarcoidosis may necessitate prompt and aggressive immunosuppressive treatment to prevent a poor visual outcome.
